Myeloablative radioimmunotherapy with Re-188-labeled anti-CD66a,b,c,e-antibody for conditioning of high-risk ALL and CML patients prior to stem cell transplantation

Buchmann, I; Reske, SN; Kotzerke, J; Martin, H; Glatting, G; Seitz, U; Rattat, Dirk; Wiesneth, M; Dohr, D; Buck, A; Bergmann, L; Doehner, H; von Harsdorf, S; Stefanic, M; Duncker, C; Bunjes, D

Myeloablative radioimmunotherapy with Re-188-labeled anti-CD66a,b,c,e-antibody for conditioning of high-risk ALL and CML patients prior to stem cell transplantation

Author:

Buchmann, I

Reske, SN ; Kotzerke, J ; Martin, H ; Glatting, G ; Seitz, U ; Rattat, Dirk ; Wiesneth, M ; Dohr, D ; Buck, A ; Bergmann, L ; Doehner, H ; von Harsdorf, S ; Stefanic, M ; Duncker, C ; Bunjes, D

Keywords:

1102 Cardiorespiratory Medicine and Haematology, 1103 Clinical Sciences, 1114 Paediatrics and Reproductive Medicine, Immunology